PR Newswire BiotechOriginal article
Epilepsia Open publishes results of post hoc data analysis of FINTEPLA® (fenfluramine) in patients with Lennox-Gastaut syndrome
Data ReadoutFINTEPLAPositive
AI Analysis
Summary
Epilepsia Open published post hoc data analysis results of FINTEPLA (fenfluramine) in patients with Lennox-Gastaut syndrome. FINTEPLA is FDA-approved for treating seizures in LGS and Dravet syndrome patients aged two years and older.
Outcome Details
Post hoc data analysis of FINTEPLA in patients with Lennox-Gastaut syndrome published
Importance:3/10
Sentiment:
0.30
FINTEPLAfenfluramineLennox-Gastaut syndromeDravet syndromepost hoc analysisFDA approved
Read the original article
Published by PR Newswire Biotech on August 5, 2026 2:40 PM